Team Identifies Novel Biomarker for Head and Neck Cancer, Non-Small Cell Lung Cancer | Lung Cancer Dispatch | Scoop.it

"A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.


"The findings, which were published this week online ahead of print by the journal Cancer, focus on a protein called Choline phosphate cytidylyltransferase-α CCT-α or CCTα, an 'antigen' that prompts the immune system to produce antibodies against it."